Petco Health and Wellness Company, Inc. (WOOF) Financial Ratios
8 years of historical data (2018–2025) · Consumer Cyclical · Specialty Retail
EV/EBITDA
↓
10.57
↓-26% vs avg
5yr avg: 14.20
30Y Low10.6·High22.7
P/FCF
↓
4.00
↓-85% vs avg
5yr avg: 27.41
30Y Low4.1·High50.3
P/B Ratio
↓
0.64
↓-42% vs avg
5yr avg: 1.10
30Y Low0.6·High2.7
ROE
↓
0.8%
↓+106% vs avg
5yr avg: -13.7%
30Y Low-72%·High8%
Debt/EBITDA
↑
9.02
+15% vs avg
5yr avg: 7.81
30Y Low7.0·High16.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
WOOF Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Petco Health and Wellness Company, Inc. trades at 82.6x earnings, 67% above its 5-year average of 49.6x, sitting at the 67th percentile of its historical range. Compared to the Consumer Cyclical sector median P/E of 21.2x, the stock trades at a premium of 291%. On a free-cash-flow basis, the stock trades at 4.0x P/FCF, 85% below the 5-year average of 27.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $748M | $770M | $935M | $664M | $3.1B | $4.9B | $5.5B | — | — |
| Enterprise Value | $3.4B | $3.4B | $3.7B | $3.6B | $6.1B | $7.7B | $8.4B | — | — |
| P/E Ratio → | 82.65 | 84.86 | — | — | 34.53 | 29.52 | — | — | — |
| P/S Ratio | 0.13 | 0.13 | 0.15 | 0.11 | 0.52 | 0.84 | 1.11 | — | — |
| P/B Ratio | 0.64 | 0.66 | 0.84 | 0.56 | 1.31 | 2.15 | 2.67 | — | — |
| P/FCF | 4.00 | 4.12 | 18.82 | — | 45.93 | 40.77 | 50.29 | — | — |
| P/OCF | 2.38 | 2.45 | 5.26 | 3.08 | 9.02 | 13.56 | 20.42 | — | — |
P/E links to full P/E history page with 30-year chart
WOOF EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Petco Health and Wellness Company, Inc.'s enterprise value stands at 10.6x EBITDA, 26% below its 5-year average of 14.2x. The Consumer Cyclical sector median is 12.2x, placing the stock at a 13% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.57 | 0.61 | 0.57 | 1.00 | 1.32 | 1.70 | — | — |
| EV / EBITDA | 10.57 | 10.64 | — | — | 14.43 | 17.54 | 22.68 | — | — |
| EV / EBIT | 27.83 | 23.02 | 239.52 | — | 28.30 | 27.50 | 47.17 | — | — |
| EV / FCF | — | 18.04 | 75.04 | — | 89.04 | 64.59 | 76.79 | — | — |
WOOF Profitability
Margins and return-on-capital ratios measuring operating efficiency
Petco Health and Wellness Company, Inc. earns an operating margin of 2.0%, roughly in line with the Consumer Cyclical sector average. Operating margins have expanded from -18.9% to 2.0% over the past 3 years, signaling improving operational efficiency. ROE of 0.8% is modest, trailing the sector median of 5.3%. ROIC of 2.4% represents below-average returns on invested capital versus a sector median of 5.2%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.7% | 38.7% | 38.0% | 37.6% | 40.2% | 41.8% | 42.8% | 43.0% | 43.4% |
| Operating Margin | 2.0% | 2.0% | 0.1% | -18.9% | 3.7% | 4.6% | 4.0% | 2.5% | -4.9% |
| Net Profit Margin | 0.2% | 0.2% | -1.7% | -20.5% | 1.5% | 2.8% | -0.5% | -2.2% | -9.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.8% | 0.8% | -8.9% | -71.8% | 3.9% | 7.6% | -2.0% | -16.0% | -64.9% |
| ROA | 0.2% | 0.2% | -1.9% | -21.4% | 1.4% | 2.6% | -0.4% | -1.7% | -8.4% |
| ROIC | 2.4% | 2.4% | 0.1% | -18.8% | 3.3% | 4.0% | 2.9% | 1.9% | -4.4% |
| ROCE | 3.0% | 3.0% | 0.2% | -24.0% | 4.1% | 5.0% | 3.7% | 2.3% | -4.9% |
WOOF Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Petco Health and Wellness Company, Inc. carries a Debt/EBITDA ratio of 9.0x, which is highly leveraged (89% above the sector average of 4.8x). Net debt stands at $2.6B ($2.9B total debt minus $257M cash). Interest coverage of just 1.1x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.46 | 2.46 | 2.66 | 2.57 | 1.32 | 1.35 | 1.46 | 8.36 | 5.06 |
| Debt / EBITDA | 9.02 | 9.02 | — | — | 7.47 | 6.95 | 8.13 | 16.51 | — |
| Net Debt / Equity | — | 2.24 | 2.51 | 2.46 | 1.23 | 1.26 | 1.41 | 8.10 | 4.77 |
| Net Debt / EBITDA | 8.21 | 8.21 | — | — | 6.99 | 6.47 | 7.83 | 15.99 | — |
| Debt / FCF | — | 13.93 | 56.22 | — | 43.11 | 23.82 | 26.50 | — | 55.53 |
| Interest Coverage | 1.12 | 1.12 | 0.11 | -7.77 | 2.10 | 3.62 | 0.81 | 0.44 | -0.88 |
WOOF Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.90x is below 1.0, meaning current liabilities exceed current assets. The quick ratio of 0.38x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.90 | 0.90 | 0.85 | 0.86 | 0.99 | 1.02 | 0.89 | 0.84 | 1.40 |
| Quick Ratio | 0.38 | 0.38 | 0.28 | 0.24 | 0.36 | 0.38 | 0.27 | 0.28 | 0.54 |
| Cash Ratio | 0.23 | 0.23 | 0.15 | 0.11 | 0.20 | 0.20 | 0.13 | 0.18 | 0.33 |
| Asset Turnover | — | 1.15 | 1.18 | 1.17 | 0.91 | 0.89 | 0.81 | 0.72 | 0.89 |
| Inventory Turnover | 6.20 | 6.20 | 5.80 | 5.70 | 5.53 | 5.01 | 5.22 | 5.28 | 5.29 |
| Days Sales Outstanding | — | 2.80 | 2.41 | 2.59 | 3.00 | 3.50 | 3.10 | 2.59 | 2.32 |
WOOF Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Petco Health and Wellness Company, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 1.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.2% | 1.2% | — | — | 2.9% | 3.4% | — | — | — |
| FCF Yield | 25.0% | 24.3% | 5.3% | — | 2.2% | 2.5% | 2.0% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $286M | $273M | $268M | $266M | $265M | $211M | $1.5B | $1.5B |
Peer Comparison
Compare WOOF with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 WOOFYou | $748M | 82.6 | 10.6 | 4.0 | 38.7% | 2.0% | 0.8% | 2.4% | 9.0 |
 CHWY | $8B | 35.0 | 18.9 | 13.4 | 29.8% | 2.0% | 58.7% | 105.2% | 1.5 |
 FRPT | $3B | 20.8 | 16.4 | 218.4 | 38.6% | 8.6% | 12.3% | 5.3% | 3.1 |
 TRUP | $1B | 52.3 | 26.3 | 13.6 | 28.5% | 1.5% | 5.5% | 5.1% | 3.0 |
 IDXX | $45B | 43.0 | 31.1 | 42.4 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 BARK | $87M | -2.2 | — | — | 61.3% | -10.2% | -45.5% | -33.3% | — |
 PETS | $37M | -0.6 | — | — | 28.1% | -17.5% | -100.4% | -119.4% | — |
 ZTS | $33B | 13.1 | 9.8 | 14.5 | 70.5% | 38.0% | 66.0% | 26.9% | 2.3 |
 ELAN | $12B | -51.5 | 16.7 | 42.6 | 43.5% | 5.3% | -3.7% | 1.9% | 4.3 |
 TGT | $59B | 16.1 | 9.3 | 20.9 | 25.4% | 4.6% | 24.0% | 12.0% | 2.5 |
 WMT | $934B | 42.9 | 22.5 | 62.6 | 24.9% | 4.2% | 21.5% | 14.4% | 1.5 |
| Consumer Cyclical Median | — | 21.2 | 12.2 | 15.6 | 36.2% | 2.0% | 5.3% | 5.2% | 4.8 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
WOOF — Frequently Asked Questions
Quick answers to the most common questions about buying WOOF stock.
What is Petco Health and Wellness Company, Inc.'s P/E ratio?
Petco Health and Wellness Company, Inc.'s current P/E ratio is 82.6x. The historical average is 49.6x. This places it at the 67th percentile of its historical range.
What is Petco Health and Wellness Company, Inc.'s EV/EBITDA?
Petco Health and Wellness Company, Inc.'s current EV/EBITDA is 10.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.3x.
What is Petco Health and Wellness Company, Inc.'s ROE?
Petco Health and Wellness Company, Inc.'s return on equity (ROE) is 0.8%. The historical average is -18.9%.
Is WOOF stock overvalued?
Based on historical data, Petco Health and Wellness Company, Inc. is trading at a P/E of 82.6x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Petco Health and Wellness Company, Inc.'s profit margins?
Petco Health and Wellness Company, Inc. has 38.7% gross margin and 2.0% operating margin.
How much debt does Petco Health and Wellness Company, Inc. have?
Petco Health and Wellness Company, Inc.'s Debt/EBITDA ratio is 9.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.